Simply reducing the number of opioid prescriptions is not enough, the report authors wrote. Hospitals must be much more proactive in identifying patients with opioid use disorder and initiating treatment wherever those patients are encountered within the treatment process.
A new committee opinion issued by the American College of Obstetricians and Gynecologists, in conjunction with the Women’s Preventive Services Initiative’s rollout of a “Well-Woman Chart,” is designed to help clinicians follow the latest updates for preventive care.
The U.S. Preventive Services Task Force has issued a final recommendation statement and evidence summary upholding its earlier recommendation against use of hormone therapy for the primary prevention of chronic conditions in postmenopausal women.
The Centers for Disease Control and Prevention is revising its recommendation on the use of the progestin-only contraception injection depot medroxyprogesterone acetate (DMPA) by women at high risk for HIV from Category 1 (no restriction) to Category 2 (benefits outweigh theoretical or proven risks).